본문

서브메뉴

Identification of Potential Therapeutic Targets in Advanced Prostate Cancer- [electronic resource]
Identification of Potential Therapeutic Targets in Advanced Prostate Cancer - [electronic ...
Contents Info
Identification of Potential Therapeutic Targets in Advanced Prostate Cancer- [electronic resource]
Material Type  
 학위논문
 
0016931197
Date and Time of Latest Transaction  
20240214095934
ISBN  
9798379774783
DDC  
574
Author  
Yang, Nianxin.
Title/Author  
Identification of Potential Therapeutic Targets in Advanced Prostate Cancer - [electronic resource]
Publish Info  
[S.l.] : University of California, Davis., 2022
Publish Info  
Ann Arbor : ProQuest Dissertations & Theses, 2022
Material Info  
1 online resource(63 p.)
General Note  
Source: Dissertations Abstracts International, Volume: 85-01, Section: B.
General Note  
Advisor: Chen, Hongwu.
학위논문주기  
Thesis (Ph.D.)--University of California, Davis, 2022.
Restrictions on Access Note  
This item must not be sold to any third party vendors.
Abstracts/Etc  
요약Metastatic castration-resistant prostate cancer (mCRPC) features high intratumoral cholesterol levels, due to aberrant regulation of cholesterol homeostasis. However, the underlying mechanisms are still poorly understood. The retinoid acid receptor-related orphan receptor gamma (RORγ), an attractive therapeutic target for cancer and autoimmune diseases, is strongly implicated in prostate cancer progression. We demonstrate in this study that in mCRPC cells and tumors, RORγ plays a crucial role in deregulation of cholesterol homeostasis. First, we found that RORγ activates the expression of key cholesterol biosynthesis proteins, including HMGCS1, HMGCR, and SQLE. Interestingly, we also found that RORγ inhibition induces cholesterol efflux gene program including ABCA1, ABCG1 and ApoA1. Our further studies revealed that liver X receptors (LXRα and LXRβ), the master regulators of cholesterol efflux pathway, mediate the function of RORγ in repression of cholesterol efflux. Finally, we demonstrated that RORγ antagonist in combination with statins has synergistic effect in killing mCRPC cells through blocking statin-induced feedback induction of cholesterol biosynthesis program and that the combination treatment also elicits stronger anti-tumor effects than either alone. Altogether, our work revealed that in mCRPC, RORγ contributes to aberrant cholesterol homeostasis by induction of cholesterol biosynthesis program and suppression of cholesterol efflux genes. Our findings support a therapeutic strategy of targeting RORγ alone or in combination with statin for effective treatment of mCRPC.Treatment-induced neuroendocrine prostate cancer (tNEPC) is an advanced, aggressive, and treatment-resistant subtype of prostate cancer that has lost dependency on androgen receptor (AR) signaling and develops neuroendocrine traits. However, the mechanisms by which tNEPC cells survive and proliferate are still poorly understood. Histone deacetylases (HDACs) have been studied in various types of cancers, and a number of HDAC inhibitors has been developed and tested in clinical studies. In this study, we demonstrate that in tNEPC cells, HDACs play vital role in tNEPC cell survival and proliferation, while also possess potential anti-cancer functions. First, we found that HDAC inhibition blocks NEPC cell growth. Notably, HDAC pan-inhibitors and some specific HDAC-selective inhibitors display high potency in tNEPC cell growth inhibition. Next, we found that HDAC inhibitors downregulate cell cycle and cell survival related gene programs. Interestingly, some pro-metastasis and neuroendocrine development gene programs are induced by HDAC inhibitors. Finally, using specific HDAC-selective inhibitors, we identified several potential candidates that play essential roles in tNEPC cells, including HDAC1, HDAC3, HDAC4, and HDAC5. Together, our findings identify HDACs as potential therapeutic targets for tNEPC and point out that additional target-specific compounds with less non-intended side-effects need to be developed.
Subject Added Entry-Topical Term  
Biology.
Subject Added Entry-Topical Term  
Molecular biology.
Subject Added Entry-Topical Term  
Cellular biology.
Subject Added Entry-Topical Term  
Oncology.
Index Term-Uncontrolled  
Intratumoral cholesterol levels
Index Term-Uncontrolled  
Cholesterol efflux
Index Term-Uncontrolled  
Biosynthesis proteins
Index Term-Uncontrolled  
Deregulation
Added Entry-Corporate Name  
University of California, Davis Biochemistry Molecular Cellular and Developmental Biology
Host Item Entry  
Dissertations Abstracts International. 85-01B.
Host Item Entry  
Dissertation Abstract International
Electronic Location and Access  
로그인을 한후 보실 수 있는 자료입니다.
소장사항  
202402 2024
Control Number  
joongbu:641353
New Books MORE
최근 3년간 통계입니다.

Detail Info.

  • Reservation
  • 캠퍼스간 도서대출
  • 서가에 없는 책 신고
  • My Folder
Material
Reg No. Call No. Location Status Lend Info
TQ0027270 T   원문자료 열람가능/출력가능 열람가능/출력가능
마이폴더 부재도서신고

* Reservations are available in the borrowing book. To make reservations, Please click the reservation button

해당 도서를 다른 이용자가 함께 대출한 도서

Related books

Related Popular Books

도서위치